دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00116-7
Volume 21, Issue 4, April 2023, Pages A7-A8
Signet Ring Cell Esophageal Adenocarcinoma: A Rare Histologic Variant
Muhammad B. Hammami, 1 Harris G. Yfantis, 2 and Jean-Pierre Raufman
doi : 10.1016/j.cgh.2022.06.034
Volume 21, Issue 4, April 2023, Pages A11-A12
Sigmoid Perforation Caused by an Aortobifemoral Vascular Graft
Emmanouil Telakis, 1 Ioannis Kalantzis, 2 and Konstantinos Goumas
doi : 10.1016/j.cgh.2022.06.035
Volume 21, Issue 4, April 2023, Page A13
A Rare Cause of Sister Mary Joseph Nodule
Yu-Chia Wang, 1 Hui-Ting Hsu,2 and Hsu-Heng Yen
doi : 10.1016/j.cgh.2022.09.017
Volume 21, Issue 4, April 2023, Page A14
Blue Notes
CHARLES J. KAHI, MD, MS, AGAF
doi : 10.1016/j.cgh.2023.01.023
Volume 21, Issue 4, April 2023, Pages 861-862
Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology
ALEXANDER GOLDOWSKY * JULIA DINGCHRISTOPHER VÉLEZSONALI PAUL
doi : 10.1016/j.cgh.2023.01.008
Volume 21, Issue 4, April 2023, Pages 863-867
Integrating Ergonomics into Endoscopy Training: A Guide for Faculty and Fellows
RISHAD KHAN, MDALEC FAGGEN, MDAMANDEEP SHERGILL, MD, MSSAMIR C. GROVER, MD, MEdCATHARINE M. WALSH, MD, MEd, PhD
doi : 10.1016/j.cgh.2022.12.036
Volume 21, Issue 4, April 2023, Pages 868-872
Practice Management: Fulfilling Trainee Education While Maintaining a High-Quality Endoscopy Unit
Manisha Apte 1 and Audrey H. Calderwood
doi : 10.1016/j.cgh.2022.12.021
Volume 21, Issue 4, April 2023, Pages 873-877.e1
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease
Anusha Shirwaikar Thomas, 1 Stephen Hanauer, 2 and Yinghong Wang
doi : 10.1016/j.cgh.2022.10.004
Volume 21, Issue 4, April 2023, Pages 878-890
AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary
Sarah K. McGill, 1 Jana G. Hashash,2,3 and Thomas A. Platts-Mills
doi : 10.1016/j.cgh.2022.12.035
Volume 21, Issue 4, April 2023, Pages 891-896
Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective
Kavish R. Patidar, 1 Salvatore Piano, 2 Giuseppe Cullaro, 3 Justin M. Belcher, 4 and Andrew S. Allegretti, 5 from the HRS-Harmony Consortia
doi : 10.1016/j.cgh.2022.12.034
Volume 21, Issue 4, April 2023, Pages 897-901.e1
Towards Improving Diagnosis of Dyssynergic Defecation: A Small Step or a New Paradigm?
KELLY L. BUCHANAN KELLY L. BUCHANAN
doi : 10.1016/j.cgh.2022.06.036
Volume 21, Issue 4, April 2023, Pages 902-906
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Virginia Solitano, 1, * Antonio Facciorusso, 2, * Tine Jess, 3,4 Christopher Ma, 5,6,7 Cesare Hassan, 1,8 Alessandro Repici, 1,8 Vipul Jairath, 7,9,10 Alessandro Armuzzi, 1,8 and Siddharth Singh
doi : 10.1016/j.cgh.2022.07.032
Volume 21, Issue 4, April 2023, Pages 907-921.e2
Estimating the Global Burden of Epstein-Barr Virus–Associated Gastric Cancer: A Systematic Review and Meta-Analysis
Mayo Hirabayashi, Damien Georges, Gary M. Clifford, and Catherine de Martel
doi : 10.1016/j.cgh.2022.07.042
Volume 21, Issue 4, April 2023, Pages 922-930.e21
Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Cheng Han Ng, 1, * Wen Hui Lim,1, * Grace En Hui Lim,2, * Darren Jun Hao Tan, 1 Nicholas Syn, 1,3 Mark D. Muthiah, 1,4,5 Daniel Q. Huang, 1,4,5,6,§ and Rohit Loomba
doi : 10.1016/j.cgh.2022.04.014
Volume 21, Issue 4, April 2023, Pages 931-939.e5
Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality
Peter Konyn, 1 Omar Alshuwaykh,2 Brittany B. Dennis, 3 George Cholankeril, 4,5 Aijaz Ahmed, 2 and Donghee Kim
doi : 10.1016/j.cgh.2022.04.043
Volume 21, Issue 4, April 2023, Pages 940-948.e2
Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials
Yuichi Mori, 1,2,3, * Pu Wang, 4, * Magnus Løberg, 1,2 Masashi Misawa,3 Alessandro Repici, 5,6 Marco Spadaccini, 5 Loredana Correale, 5 Giulio Antonelli, 7,8 Honggang Yu, 9,10,11 Dexin Gong, 9,10,11 Misaki Ishiyama, 3 Shin-ei Kudo, 3 Shunsuke Kamba, 12 Kazuki Sumiyama, 12 Yutaka Saito, 13 Haruo Nishino, 14 Peixi Liu, 4 Jeremy R. Glissen Brown, 15 Nabil M. Mansour, 16 Seth A. Gross, 17 Mette Kalager, 1,2 Michael Bretthauer, 1,2 Douglas K. Rex, 18 Prateek Sharma, 19 Tyler M. Berzin, 20 and Cesare Hassan
doi : 10.1016/j.cgh.2022.08.022
Volume 21, Issue 4, April 2023, Pages 949-959.e2
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma
Yu-Han Huang,*,a Chi Chan,*,a Hye-Won Lee,‡ Claire Huang,* ,§ Yen-Ju Chen,* ,§ Po-Chun Liu,*,§ Sheng-Nan Lu,jj Wan-Long Chuang, ¶,#, ** Jee-Fu Huang, ¶,#, ** ,‡‡,§§ Ming-Lung Yu, ¶,#, **,‡‡ Jill Koshiol,jjjj and Mei-Hsuan Lee
doi : 10.1016/j.cgh.2022.01.046
Volume 21, Issue 4, April 2023, Pages 960-969.e1
The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression
Zobair M. Younossi, 1,2,3 Maria Stepanova, 1,2,4 Robert P. Myers, 5 Issah Younossi, 4 and Linda Henry
doi : 10.1016/j.cgh.2022.04.023
Volume 21, Issue 4, April 2023, Pages 970-977.e1
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study
Georg Semmler, 1,2 Alexander Lindorfer, 3 Benedikt Schäfer, 4 Stefan Bartl, 5 Stephanie Hametner-Schreil, 3 Sophie Gensluckner, 6 Lorenz Balcar, 1,2 Katharina Pomej, 1,2 Katharina Lampichler, 7 Michael Trauner, 1 Elmar Aigner, 6 Christian Datz, 8 Heinz Zoller, 4 Harald Hofer, 5 Rainer Schöfl, 3 Mattias Mandorfer,1,2 Thomas Reiberger, 1,2,9 and Bernhard Scheiner
doi : 10.1016/j.cgh.2022.04.024
Volume 21, Issue 4, April 2023, Pages 978-987.e2
Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C
Joslyn Strebe, 1 Nicole E. Rich, 1,2 Li Wang, 3 Amit G. Singal, 1,2,3 Jennifer McBryde, 1,3 Mauro Silva, 1 Victoria Jackson, 1 Hannah Fullington, 3 Deyaun L. Villarreal, 3 Stephanie Reyes, 3 Bertha Flores, 4 and Mamta K. Jain, MD, MPH
doi : 10.1016/j.cgh.2022.04.031
Volume 21, Issue 4, April 2023, Pages 988-994.e2
Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study
Fredrik Åberg, 1 Rupesh Rajani,2,3 Axel Wester, 3 Linnea Widman, 4 and Hannes Hagström 2,3,5
doi : 10.1016/j.cgh.2022.04.032
Volume 21, Issue 4, April 2023, Pages 995-1004.e9
Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists
Alyson Kaplan, 1 Lauren Comisar, 2 Nneka N. Ufere, 3 Deanna Jannat-Khah,2 Russell Rosenblatt, 1 Brett Fortune, 1 Holly G. Prigerson, 2,§ and Robert Brown Jr.
doi : 10.1016/j.cgh.2022.04.042
Volume 21, Issue 4, April 2023, Pages 1005-1012.e4
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
Takanori Ito, 1 Vy H. Nguyen, 2 Taku Tanaka, 1 Huiyul Park, 3 Ming-Lun Yeh, 4 Miwa Kawanaka, 5 Taeang Arai, 6 Masanori Atsukawa, 6 Eileen L. Yoon, 3 Pei-Chien Tsai, 4 Hidenori Toyoda, 7 Jee-Fu Huang, 4 Linda Henry, 2 Dae Won Jun, 3 Ming-Lung Yu, 4 Masatoshi Ishigami, 1 Mindie H. Nguyen, 2,8 and Ramsey C. Cheung
doi : 10.1016/j.cgh.2022.05.015
Volume 21, Issue 4, April 2023, Pages 1013-1022.e6
Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis
Hyun-seok Kim, 1 Priya B. Shetty, 2 Spiridon Tsavachidis, 2 Jing Dong, 2,3 Christopher I. Amos, 2,4 Hashem B. El-Serag, 1,5 and Aaron P. Thrift
doi : 10.1016/j.cgh.2022.05.020
Volume 21, Issue 4, April 2023, Pages 1023-1030.e39
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort
Jasmohan S. Bajaj,* Puneeta Tandon,‡ Jacqueline G. O’Leary, § K. Rajender Reddy,k Guadalupe Garcia-Tsao, ¶ Paul Thuluvath,# Jennifer C. Lai,** Ram M. Subramanian,‡‡ Hugo E. Vargas, §§ Florence Wong,kk Andrew Fagan,* Sara McGeorge,* Leroy R. Thacker,* and Patrick S. Kamath
doi : 10.1016/j.cgh.2022.03.046
Volume 21, Issue 4, April 2023, Pages 1031-1040.e3
Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
Huiyul Park, 1, * Eileen L. Yoon, 2, * Mimi Kim, 3 Seon Cho, 4 Eun-Hee Nah, 4,§ and Dae Won Jun 2,§
doi : 10.1016/j.cgh.2022.04.012
Volume 21, Issue 4, April 2023, Pages 1041-1049.e3
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis
Emily C. L. Wong, 1 Parambir S. Dulai, 2 John K. Marshall, 1 Vipul Jairath,3 Walter Reinisch,4 and Neeraj Narula
doi : 10.1016/j.cgh.2022.08.015
Volume 21, Issue 4, April 2023, Pages 1050-1060.e9
The Prevalence, Humanistic Burden, and Health Care Impact of Irritable Bowel Syndrome Among United States Veterans
Andrea Shin, 1 Huiping Xu, 2 and Thomas F. Imperiale
doi : 10.1016/j.cgh.2022.08.005
Volume 21, Issue 4, April 2023, Pages 1061-1069.e1
Utility of Anorectal Testing to Predict Outcomes With Pelvic Floor Physical Therapy in Chronic Constipation: Pragmatic Trial
Eric D. Shah, 1 Elizabeth A. Pelletier, 1 Carol Greeley, 1 Emily E. Sieglinger, 1 Jamie D. Sanchez, 1 Kayla A. Northam, 1 Jessica A. Perrone, 1 Michael A. Curley, 1 Christopher M. Navas, 1 Tracy L. Ostler, 1 Aimee R. Burnett Greeley, 2 Pablo Martinez-Camblor, 3 Jason R. Baker, 4 and William D. Chey
doi : 10.1016/j.cgh.2022.05.014
Volume 21, Issue 4, April 2023, Pages 1070-1081
An Office-Based, Point-of-Care Test Predicts Treatment Outcomes With Community-Based Pelvic Floor Physical Therapy in Patients With Chronic Constipation
Eric D. Shah,* Elizabeth A. Pelletier,* Carol Greeley,* Emily E. Sieglinger,* Jamie D. Sanchez,* Kayla A. Northam,* Jessica A. Perrone,* Michael A. Curley,* Christopher M. Navas,* Tracy L. Ostler,* Aimee R. Burnett Greeley,‡ Pablo Martinez-Camblor, § Jason R. Baker,k Adrienne Harris, ¶ Corey A. Siegel,* and William D. Chey
doi : 10.1016/j.cgh.2022.03.022
Volume 21, Issue 4, April 2023, Pages 1082-1090
Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations
ASHWINI ARVINDSAGAR JOSHITIMOTHY ZAKIDANIEL BURKHOLDERNEEHAR D. PARIKHAMIT G. SINGAL
doi : 10.1016/j.cgh.2021.11.042
Volume 21, Issue 4, April 2023, Pages 1091-1093.e3
Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
HALEY SCHOENBERGER NICOLE E. RICHPATRICIA JONESSRUTHI YEKKALURIADAM YOPPAMIT G. SINGAL
doi : 10.1016/j.cgh.2021.12.027
Volume 21, Issue 4, April 2023, Pages 1094-1096.e2
Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology
JARED A. SNINSKYJOSEPH GALANKOROBERT S. SANDLERANNE F. PEERY
doi : 10.1016/j.cgh.2022.02.020
Volume 21, Issue 4, April 2023, Pages 1097-1099.e3
Performance of Vibration-Controlled Transient Elastography and Clinical Prediction Models In Liver Transplant Recipients
MOHAMMAD SHADAB SIDDIQUIANH T. BUITASEEN SYEDMICHAEL TSENGCHANDRA S. BHATI
doi : 10.1016/j.cgh.2022.02.023
Volume 21, Issue 4, April 2023, Pages 1100-1102.e2
Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy
SHIVA POOLAMARYKATE KRATZERSIRISH SANAKAKERRY SEWELLHANS L. TILLMANN
doi : 10.1016/j.cgh.2022.02.027
Volume 21, Issue 4, April 2023, Pages 1103-1104.e3
Long-Term Effect of PNPLA3 on the Aggravation of Nonalcoholic Fatty Liver Disease in a Biopsy-Proven Cohort
BO KYUNG KOOHYUNSUK LEESOO-HEON KWAKDONG HYEON LEEJEONG HWAN PARKWON KIM
doi : 10.1016/j.cgh.2022.02.026
Volume 21, Issue 4, April 2023, Pages 1105-1107.e3
Quantitative Analysis of Tug Sign: An Endoscopic Finding of Eosinophilic Esophagitis
ERIC A. PASMANZACHARY RUBINALEXANDER R. HOOPERNATHAN KOLASINSKIFOUAD J. MOAWADSTEVE B. MIN
doi : 10.1016/j.cgh.2022.02.042
Volume 21, Issue 4, April 2023, Pages 1108-1110.e1
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
JENNIFER R. KRAMERPETER A. RICHARDSONHYUNSEOK KIMYAO-CHUN HSUFASIHA KANWALHASHEM B. EL-SERAG
doi : 10.1016/j.cgh.2022.02.056
Volume 21, Issue 4, April 2023, Pages 1111-1113.e3
Exam 1: Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease
doi : 10.1016/j.cgh.2023.01.021
Volume 21, Issue 4, April 2023, Pages e15-e16
Exam 2: Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective
doi : 10.1016/j.cgh.2023.01.022
Volume 21, Issue 4, April 2023, Page e17
Nomenclature Dilemma of MAFLD Across the Globe: Our Prism to Understand Metabolic Dysfunction and Cardiovascular Risk in MAFLD
GEORG SEMMLER, MDSARAH WERNLY, MD BERNHARD WERNLY, MD, PhD CHRISTIAN DATZ, MD
doi : 10.1016/j.cgh.2022.05.033
Volume 21, Issue 4, April 2023, Pages 1114-1115
Reply
EILEEN L. YOON, MD, PhDHUIYUL PARK, MD, PhDDAE WON JUN, MD, PhD
doi : 10.1016/j.cgh.2022.06.010
Volume 21, Issue 4, April 2023, Pages 1115-1116
Predicting the Development of Chronic Cholecystitis: Does It Matter?
LI-YANG SUN, MDGANG HOU, MD
doi : 10.1016/j.cgh.2022.05.012
Volume 21, Issue 4, April 2023, Pages 1116-1117
Direct Oral Anticoagulants in Budd-Chiari Syndrome: Need a Closer Look!
ANKUR JINDAL, MD, DMAMAR MUKUND, MD
doi : 10.1016/j.cgh.2022.05.034
Volume 21, Issue 4, April 2023, Page 1117
Reply
GEORG SEMMLER, MDTHOMAS REIBERGER, MDBERNHARD SCHEINER, MD, PhD
doi : 10.1016/j.cgh.2022.06.014
Volume 21, Issue 4, April 2023, Pages 1117-1119
Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain
HEIDI M. STAUDACHER, B App Sci, M Nutr Diet,PETER R. GIBSON, MBBS(Hons), MD, FRACP
doi : 10.1016/j.cgh.2022.05.051
Volume 21, Issue 4, April 2023, Pages 1119-1120
Reply
ANUPAM REJ, MDDAVID S. SANDERS, MD IMRAN AZIZ, MD
doi : 10.1016/j.cgh.2022.06.024
Volume 21, Issue 4, April 2023, Pages 1120-1121
Obesity and Risk of Crohn’s Disease Half the Story
MICHAEL A. MENDALL, MA, MD, FRCP
doi : 10.1016/j.cgh.2022.05.031
Volume 21, Issue 4, April 2023, Pages 1121-1122
Reply
SIMON S. M. CHAN, MB BChir, PhDHAMED KHALILI, MD, MPH
doi : 10.1016/j.cgh.2022.07.004
Volume 21, Issue 4, April 2023, Page 1122
Does Fatty Liver Play a Role in the Risk of All-Cause and Cause-Specific Mortality in Patients with Gallstone Disease?
JIARONG XIE, MS LEI XU, MD
doi : 10.1016/j.cgh.2022.06.022
Volume 21, Issue 4, April 2023, Page 1123
Reply
DONGHEE KIM, MD, PHDPETER KONYN, MDAIJAZ AHMED, MD
doi : 10.1016/j.cgh.2022.08.002
Volume 21, Issue 4, April 2023, Pages 1123-1124
